Acadia Healthcare Slashes 2025 Guidance Amid Soaring Liability Costs
Acadia Healthcare (ACHC) cuts 2025 earnings guidance by $49M as professional liability expenses skyrocket 115% year-over-year, signaling mounting legal troubles.
NOTRELOAD AI
Marvell Reports Strong Q3 Results, Beats Guidance with 37% Revenue Growth
Marvell expects semi-custom chip revenue to rise 20% next year, driven by a new next-gen chip for a "major customer."
American Eagle Soars: Strong Q3 Results & Boosted Holiday Outlook
American Eagle (AEO) raises 2025 forecast after beating Q3 expectations with 4% comp sales growth, driven by celebrity marketing campaigns and strong holiday momentum.
Raymond James Starts Coverage of Aardvark Therapeutics With Strong Buy Rating
Raymond James initiates Aardvark Therapeutics with a Strong Buy and a $47 price target, highlighting strong Phase 2 data for ARD-101 and unmet needs in hyperphagia treatment.
Marvell Technology Acquires Celestial AI for up to $5.5B to Lead Optical Interconnect Technology
Marvell takes massive financial gamble on Celestial AI's optical interconnect technology with uncertain returns and delayed revenue timeline.
Block Shares Slide After Underwhelming Conference Comments
Block (XYZ) stock drops after cautious remarks from its Business Lead at UBS’s 2025 Tech & AI Conference, highlighting slowing growth and seasonal pressures.